Gene editing using CRISPR and CAS technologies has demonstrated significant potential in treating rare genetic diseases. These groundbreaking techniques offer hope to patients and families affected by these conditions, as traditional treatment options are often limited or non-existent. This article explores the use of CRISPR and CAS gene-editing technologies in addressing rare diseases, their challenges, and the future prospects of gene therapy in this context.
